Clinical Trials for Thyroid Cancer

Find clinical trials for thyroid cancer. Discover research opportunities and treatment options in your area.

109 Active Trials Found

Showing 109 trials on this page

Page 1 of 6

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

NCT ID: NCT05538130

This clinical trial is studying a new medicine called PF-07799544 to see how safe and effective it is for people with advanced solid tumors, such as melanoma, brain cancer, thyroid cancer, and lung...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +53 more

177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

NCT ID: NCT06991738

This clinical trial is studying a new radioactive drug called 177Lu-DOTA-EB-TATE, which is designed to help patients with a rare type of thyroid cancer known as Hurthle cell thyroid cancer (HTC). T...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

NCT ID: NCT05355701

This clinical trial is studying a new medicine called PF-07799933 to see how safe it is and how well it works for people with advanced solid tumors that have a specific gene change known as a "BRAF...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +47 more

Selective Neck Dissection Versus Modified Neck Dissection in PTC

NCT ID: NCT06554652

This clinical trial is studying two different surgical techniques for patients with a type of thyroid cancer called papillary thyroid carcinoma (PTC). The goal is to see if a procedure called selec...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, China

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

NCT ID: NCT03841617

This clinical trial is examining a new way to measure the best dose of radioactive iodine treatment for patients with advanced differentiated thyroid cancer. It compares two methods of preparing pa...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

DESTINY-PANTUMOUR04

NCT ID: NCT07124000

This clinical trial, called DESTINY-PANTUMOUR04, is studying a medicine called T-DXd to see how well it works in people with certain advanced cancers that have a specific marker called HER2-positiv...

Not yet recruiting

Type: observational

Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer

NCT ID: NCT05752604

This clinical trial is studying how different treatments and patient characteristics affect the outcomes for people with thyroid cancer. The goal is to better understand which patients have more ag...

Recruiting

Type: observational Locations: Milan, Italy, Milan, Select A State, Italy

Studies on Tumors of the Thyroid

NCT ID: NCT00001160

This clinical trial is studying different types of thyroid cancer, including Hurthle Cell, Tall Cell Variant, Follicular, and Papillary thyroid cancers. The main goal is to improve how doctors diag...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

SLV-154 Treatment of Metastatic Solid Tumors

NCT ID: NCT06771219

This clinical trial is studying a new treatment called SLV-154 for patients with certain types of metastatic solid tumors, which are cancers that have spread from their original site to other parts...

Recruiting

Phase: PHASE1 Type: interventional Locations: St. Louis, Missouri, United States, Saint Louis, Missouri, United States +3 more

A Study of Avutometinib and Defactinib in People With Thyroid Cancer

NCT ID: NCT06007924

This clinical trial is studying the use of two medications, avutometinib and defactinib, to see if they can effectively treat certain types of thyroid cancer that do not respond to standard treatme...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Allentown, Pennsylvania, United States +6 more

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT ID: NCT05503797

This clinical trial is studying a new treatment called FORE8394 for people with certain types of cancer that have specific changes in the BRAF gene. The goal is to see how effective and safe this t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Milano, Italy, New York, New York, United States +72 more

Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)

NCT ID: NCT06923826

This clinical trial is studying a drug called sacituzumab govitecan to see if it can effectively treat certain types of advanced salivary gland and thyroid cancers. Specifically, the trial focuses ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Singapore, Singapore

Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)

NCT ID: NCT07092514

This clinical trial is studying two different daily doses of a medicine called lenvatinib to treat a type of thyroid cancer that does not respond to radioactive iodine therapy. This form of thyroid...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Saint Louis, Missouri, United States

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

NCT ID: NCT06961084

This clinical trial is studying a new imaging method using Iodine-124 (I-124) to detect metastatic thyroid cancer, which means cancer that has spread from the thyroid to other parts of the body. Cu...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States, San Francisco, California, United States

Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.

NCT ID: NCT07059507

This clinical trial is looking at how often thyroid cancer is found unexpectedly in people with Graves' disease who are having their thyroid gland completely removed through surgery. Graves' diseas...

Recruiting

Type: observational Locations: Minya, Minia, Egypt

Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)

NCT ID: NCT07056218

This clinical trial is studying how well radioactive iodine therapy (called RAI131) works for people with differentiated thyroid cancer, which is a common type of thyroid cancer that usually grows ...

Not yet recruiting

Type: observational

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

NCT ID: NCT03175224

The APL-101 clinical trial is exploring a new treatment for patients with advanced lung cancer, specifically those with certain genetic changes called c-Met Exon 14 skipping mutations or MET amplif...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Madison, Wisconsin, United States +114 more

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT ID: NCT06239194

This clinical trial is testing a new treatment called MDX2001 for patients with advanced solid tumors, which are cancers that form in organs or tissues, such as breast, lung, or colorectal cancer. ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Nashville, Tennessee, United States +4 more

Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer

NCT ID: NCT05463107

This clinical trial is studying how certain proteins found in urine might help doctors diagnose follicular thyroid cancer earlier and more accurately before surgery. Thyroid cancer is common, and w...

Recruiting

Type: observational Locations: Taipei, Taiwan

Integrated Cancer Repository for Cancer Research

NCT ID: NCT02012699

The Integrated Cancer Repository for Cancer Research (iCaRe2) is a study designed to gather important information and samples from adults who have been diagnosed with cancer, those at high risk for...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States, Denver, Colorado, United States +93 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions